| David J Van Dam, CRNA | |
|
11800 E 12 Mile Rd, Warren, MI 48093-3472 | |
| (586) 573-5260 | |
| (586) 573-5364 |
| Full Name | David J Van Dam |
|---|---|
| Gender | Male |
| Speciality | Nurse Anesthetist, Certified Registered |
| Location | 11800 E 12 Mile Rd, Warren, Michigan |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1033137153 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367500000X | Nurse Anesthetist, Certified Registered | 4704115131 (Michigan) | Primary |
| Entity Name | Eastside Group Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1235365289 PECOS PAC ID: 4486790219 Enrollment ID: O20091008000624 |
News Archive
The type 3 interferons - usually called the "lambda" interferons, or "IFNL" - are the most recently identified IFNs. We (myself and Sergei Kotenko) originally identified the receptor and then the three ligands (IFNL1,2,3; very recently a fourth, IFNL4, was discovered); the key paper was published in 2003.
Researchers in the United States believe they have discovered a "master" embryonic cardiac stem cell.
The imminent death of a patient is riddled with emotions for a patient and family as well as the medical team. A study based on the reflections of third-year Loyola University Chicago Stritch School of Medicine students is shedding light on the struggle physicians in training often face when trying to control their own emotions while not becoming desensitized to the needs of the dying patient and his or her family.
Using risk stratification to assist in treatment selection was just one of the focal points at a recent presentation of the NCCN Clinical Practice Guidelines for Oncology (NCCN Guidelines™) for Acute Myeloid Leukemia (AML) at the NCCN 15th Annual Conference.
› Verified 9 days ago
| Entity Name | Rochester Medical Associates Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1396398681 PECOS PAC ID: 8729318704 Enrollment ID: O20190918002717 |
News Archive
The type 3 interferons - usually called the "lambda" interferons, or "IFNL" - are the most recently identified IFNs. We (myself and Sergei Kotenko) originally identified the receptor and then the three ligands (IFNL1,2,3; very recently a fourth, IFNL4, was discovered); the key paper was published in 2003.
Researchers in the United States believe they have discovered a "master" embryonic cardiac stem cell.
The imminent death of a patient is riddled with emotions for a patient and family as well as the medical team. A study based on the reflections of third-year Loyola University Chicago Stritch School of Medicine students is shedding light on the struggle physicians in training often face when trying to control their own emotions while not becoming desensitized to the needs of the dying patient and his or her family.
Using risk stratification to assist in treatment selection was just one of the focal points at a recent presentation of the NCCN Clinical Practice Guidelines for Oncology (NCCN Guidelines™) for Acute Myeloid Leukemia (AML) at the NCCN 15th Annual Conference.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| David J Van Dam, CRNA 11800 E 12 Mile Rd, Warren, MI 48093-3472 Ph: (586) 573-5260 | David J Van Dam, CRNA 11800 E 12 Mile Rd, Warren, MI 48093-3472 Ph: (586) 573-5260 |
News Archive
The type 3 interferons - usually called the "lambda" interferons, or "IFNL" - are the most recently identified IFNs. We (myself and Sergei Kotenko) originally identified the receptor and then the three ligands (IFNL1,2,3; very recently a fourth, IFNL4, was discovered); the key paper was published in 2003.
Researchers in the United States believe they have discovered a "master" embryonic cardiac stem cell.
The imminent death of a patient is riddled with emotions for a patient and family as well as the medical team. A study based on the reflections of third-year Loyola University Chicago Stritch School of Medicine students is shedding light on the struggle physicians in training often face when trying to control their own emotions while not becoming desensitized to the needs of the dying patient and his or her family.
Using risk stratification to assist in treatment selection was just one of the focal points at a recent presentation of the NCCN Clinical Practice Guidelines for Oncology (NCCN Guidelines™) for Acute Myeloid Leukemia (AML) at the NCCN 15th Annual Conference.
› Verified 9 days ago
Kimberly A Manzaroli, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 11800 E 12 Mile Rd, Warren, MI 48093 Phone: 586-573-5260 Fax: 586-573-5364 | |
Toleka Regina Taylor, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: St. John Macomb Hospital, 11800 East 12 Mile Road, Warren, MI 48093 Phone: 586-576-4031 | |
Metodija Naumovski, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 11800 E 12 Mile Rd, Warren, MI 48093 Phone: 586-573-5260 Fax: 586-573-5364 | |
Mr. Romulo Gasmen Pascua, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 21230 Dequindre Rd, Warren, MI 48091 Phone: 734-765-2921 | |
Norbert Kadler, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 11800 E 12 Mile Rd, Warren, MI 48093 Phone: 586-573-5260 Fax: 586-573-5364 | |
Ms. Diane Marie Pokorski, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 11800 E 12 Mile Rd, Warren, MI 48093 Phone: 586-612-4446 |